Genetic variants in the genes encoding either of these enzymes can lead to creatine deficiency syndrome (CDS), which is neurologically manifested as cerebral creatine deficiency syndrome (CCDS), with genetic variants in the genes encoding the enzymes leading to the syndromes known as CCDS2 and CCDS3, respectively. This evidence concerns the gene GAMT and cerebral creatine deficiency syndrome.